Literature DB >> 14575139

Detection of H7 avian influenza virus directly from poultry specimens.

E Starick1, O Werner.   

Abstract

Using clinical materials from experimentally infected poultry, we established an effective method for the preparation of viral RNA directly from tissue samples and eggs. Furthermore, our type A-specific matrix reverse transcription-polymerase chain reaction (RT-PCR) test was improved, and an H7 subtype-specific nested RT-PCR, which includes the hemagglutinin cleavage site, was designed. Both RT-PCR systems proved to be as sensitive as virus isolation. In addition, the labeled H7 HA-nested PCR primers were suitable for sequencing of the PCR products. The RT-PCR amplification of viral RNA and sequencing of the PCR product allows for the sensitive and rapid differentiation between low-pathogenic and highly pathogenic avian influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575139     DOI: 10.1637/0005-2086-47.s3.1187

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  3 in total

1.  The H5N1 influenza variant Fujian-like hemagglutinin selected following vaccination exhibits a compromised furin cleavage : neurological Consequences of highly pathogenic Fujian H5N1 strains.

Authors:  Antonella Pasquato; Nabil G Seidah
Journal:  J Mol Neurosci       Date:  2008-02-28       Impact factor: 3.444

2.  Scientific Report of the Scientific Panel on Biological Hazards on "Food as a possible source of infection with highly pathogenic avian influenza viruses for humans and other mammals".

Authors: 
Journal:  EFSA J       Date:  2006-03-22

3.  Conventional inactivated bivalent H5/H7 vaccine prevents viral localization in muscles of turkeys infected experimentally with low pathogenic avian influenza and highly pathogenic avian influenza H7N1 isolates.

Authors:  Anna Toffan; Maria Serena Beato; Roberta De Nardi; Elena Bertoli; Annalisa Salviato; Giovanni Cattoli; Calogero Terregino; Ilaria Capua
Journal:  Avian Pathol       Date:  2008-08       Impact factor: 3.378

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.